Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
for Breast Cancer
451 locations incl. Fairbanks
Sponsor: Canadian Cancer Trials Group
Sex: Female·Age: 35+
Code: NCT03488693·Phase 3·Recruiting
Clinical Trials at Springfield Memorial Hospital
As of June 2026, 87 paid clinical trials are recruiting at Springfield Memorial Hospital, located at 5230 S 6TH STREET RD, SPRINGFIELD, IL 62703-5128, phone (217) 585-1180 in Springfield, Illinois. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
87 clinical trials at Springfield Memorial Hospital
·Clear filters·↓ Download CSVTesting Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for Advanced Lung Non-Small Cell Carcinoma
Drug: Osimertinib
345 locations incl. Wauwatosa
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT03191149·Phase 2·Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for Childhood Extracranial Germ Cell Tumor
566 locations incl. Birmingham
Sponsor: Children's Oncology Group
Sex: All·Age: All ages
Code: NCT03067181·Phase 3·Recruiting
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
for Head and Neck Squamous Cell Carcinoma
676 locations incl. Birmingham
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All·Age: 18+
Code: NCT02734537·Phase 2·Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for Intracranial Meningioma
780 locations incl. Birmingham
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT02523014·Phase 2·Recruiting
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
for Hematopoietic and Lymphatic System Neoplasm
140 locations incl. Birmingham
Sponsor: National Cancer Institute LAO
Sex: All·Age: 2 Months+
Code: NCT02474160·Recruiting
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
for Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
Drug: Atezolizumab
338 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT01810913·Phase 2, Phase 3·Recruiting